CellaVision (Sweden) Today
| CEVI Stock | SEK 224.00 2.50 1.13% |
Performance0 of 100
| Odds Of DistressLess than 9
|
CellaVision is selling for under 224.00 as of the 28th of November 2024; that is 1.13 percent increase since the beginning of the trading day. The stock's last reported lowest price was 214.0. CellaVision has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for CellaVision AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of June 2024 and ending today, the 28th of November 2024. Click here to learn more.
CellaVision AB develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden and internationally. CellaVision AB was founded in 1994 and is headquartered in Lund, Sweden. CellaVision operates under High Precision And Instrumentation Products classification in Sweden and is traded on Stockholm Stock Exchange. The company has 23.85 M outstanding shares. More on CellaVision AB
Moving together with CellaVision Stock
Moving against CellaVision Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
CellaVision Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. CellaVision's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding CellaVision or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President | Peter Wilson |
| Business Concentration | Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) |
CellaVision AB (CEVI) is traded on Stockholm Exchange in Sweden and employs 235 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.21 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CellaVision's market, we take the total number of its shares issued and multiply it by CellaVision's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CellaVision AB operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 23.85 M outstanding shares.
CellaVision AB has accumulated about 190.2 M in cash with 159.72 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.97.
Check CellaVision Probability Of Bankruptcy
Ownership AllocationCellaVision holds a total of 23.85 Million outstanding shares. CellaVision AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check CellaVision Ownership Details
CellaVision AB Risk Profiles
Although CellaVision's alpha and beta are two of the key measurements used to evaluate CellaVision's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.83 | |||
| Standard Deviation | 2.34 | |||
| Variance | 5.47 | |||
| Risk Adjusted Performance | (0.08) |
CellaVision Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in CellaVision without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
CellaVision Corporate Management
Elected by the shareholders, the CellaVision's board of directors comprises two types of representatives: CellaVision inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CellaVision. The board's role is to monitor CellaVision's management team and ensure that shareholders' interests are well served. CellaVision's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CellaVision's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yve Thorenburg | Acting Sales | Profile | |
| Julien Veyssy | Managing Diagnostics | Profile | |
| Magnus Blixt | Ex Officer | Profile | |
| Urban Strindlov | VP Sales | Profile | |
| Maths hc | Founder Director | Profile | |
| Simon Ostergaard | CEO Pres | Profile |
Additional Tools for CellaVision Stock Analysis
When running CellaVision's price analysis, check to measure CellaVision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CellaVision is operating at the current time. Most of CellaVision's value examination focuses on studying past and present price action to predict the probability of CellaVision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CellaVision's price. Additionally, you may evaluate how the addition of CellaVision to your portfolios can decrease your overall portfolio volatility.